findmyKOL
Clinical trialNCT01620762CompletedPhase 3Interventional

Phase III Cat-PAD Study

SponsorCircassia LimitedEnrollment1,408Rhinoconjunctivitis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

118 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Belgium
  • Facility name not stated

    Brussels, Belgium

  • Facility name not stated

    Ghent, Belgium

  • Facility name not stated

    Leuven, Belgium

Canada
  • Facility name not stated

    Burlington, Ontario, Canada

  • Facility name not stated

    Corruna, Ontario, Canada

  • Facility name not stated

    Hamilton, Ontario, Canada

  • Facility name not stated

    Kanata, Ontario, Canada

  • Facility name not stated

    London, Ontario, Canada

  • Facility name not stated

    Newmarket, Ontario, Canada

  • Facility name not stated

    Niagara Falls, Ontario, Canada

  • Facility name not stated

    Oshawa, Ontario, Canada

  • Facility name not stated

    Ottawa, Ontario, Canada

  • Facility name not stated

    Toronto, Ontario, Canada

  • Facility name not stated

    Montreal, Quebec, Canada

  • Facility name not stated

    Pointe-Claire, Quebec, Canada

  • Facility name not stated

    Québec, Quebec, Canada

  • Facility name not stated

    Trois-Rivières, Quebec, Canada

Czechia
  • Facility name not stated

    Brnho, Czechia

  • Facility name not stated

    Jablonec nad Nisou, Czechia

  • Facility name not stated

    Kutná Hora, Czechia

  • Facility name not stated

    Prague, Czechia

  • Facility name not stated

    Rychnov nad Kněžnou, Czechia

  • Facility name not stated

    České Budějovice, Czechia

  • Facility name not stated

    Čáslav, Czechia

Germany
  • Facility name not stated

    Berlin, Germany

  • Facility name not stated

    Bonn, Germany

  • Facility name not stated

    Bramsche, Germany

  • Facility name not stated

    Cologne, Germany

  • Facility name not stated

    Hamburg, Germany

  • Facility name not stated

    Heidelberg, Germany

  • Facility name not stated

    Mönchengladbach, Germany

  • Facility name not stated

    München, Germany

  • Facility name not stated

    Münster, Germany

  • Facility name not stated

    Neuss, Germany

  • Facility name not stated

    Osnabrück, Germany

  • Facility name not stated

    Wesel, Germany

  • Facility name not stated

    Wiesbaden, Germany

  • Facility name not stated

    Wuppertal, Germany

Hungary
  • Facility name not stated

    Budapest, Hungary

  • Facility name not stated

    Csorna, Hungary

78 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Oct 2012
Primary completion
30 Jun 2016
Completion
Last update posted
15 Jun 2018
Registered enrollment
1,408
Registry id
NCT01620762

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.